Q2MFU6 AF NFT

2'-dehydrokanamycin reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeign6t75qfdmvbcvpeyafeqdwzgvbf6rjitvd4rfeir2zxfz5p3aza/metadata.json
IPFS of structure file: 
bafybeihev26umpfiy46w66nvi5zcofveleluoq3txwxukmxgjvhzarvpxm/AF-Q2MFU6-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x5DD335da0E7B6349A9761Bec7652a919dC6599C6
First NFT owner address (bech32): 
genesis1thfntksw0d35n2tkr0k8v54fr8wxtxwxh30ees
Current NFT ID #198158 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
198158
Accession (UniProt):
Q2MFU6
Name::
2'-dehydrokanamycin reductase
Experimental Method:
Predicted structure
Sequence source:
STREPTOMYCES KANAMYCETICUS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q2MFU6 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q2MFU6|KANK_STRKN 2'-dehydrokanamycin reductase OS=Streptomyces kanamyceticus OX=1967 GN=kanK PE=1 SV=2 MSSQLALRGPELSANLCKPEEDTLRVLVTGGSGNVGVGVVRALNAARHHVVVASRGYSPALLPEGVRAVRLERTEPDAYTRLVAAEKPDAVIDLTCHDAADAAVTLRACAGVDRVVVVSSVTAAGPATTTPVTEATAAPPLSEYGIDKLAVEETVRAAWADGTSQALLVRLGAVYRLGADLDGQLAEDGCWLAHAAAGAPAVLADDGAARWNLLHADDAGAALAELLANDRARGVLVHLASRHPLPWRELYERVHHALGRPFNPVSVPAEWAAEQLEDAEFLAETSRWDQVFDLGLLDRLAPSYQERGGPSRVTEVALWLIRQGRVGDAELGAEIQELPARLAAVRTAPGLV